MediVet Biologic’s mission is to offer innovative, safe and effective biologic treatments in regenerative medicine & oncology solutions, to assist millions of animals needlessly suffering in pain.
MediVet Biologics, a global leader in veterinary regenerative medicine and biological solutions. With corporate offices in Central, Kentucky, and Sydney, Australia and cases performed in over 29 countries around the world.
MediVet Biologics developed the first in-clinic Adipose Stem Cell Therapy kit. They continue to make advancements in veterinary regenerative medicine and biological therapeutic offerings for both equine and small animal applications. MediVet’s Adipose-Derived Stem Cell Procedure kit is a major scientific advancement in animal stem cell therapy that offers an economic solution for owners of pets suffering from osteoarthritis, hip dysplasia, ligament and cartilage injuries as well as numerous mobility ailments.
MediVet’s accomplishments in the regenerative medicine market have given way to an incredible pipeline of technological advancements and the ability to successfully bring those animal health products to market. MediVet is the only Veterinary Regenerative Medicine company to have multiple collaborative university studies further validating current technology and product pipelines. Their work boasts extensive collections of anecdotal evidence of efficacy through clinical cases and field reporting. They continue to provide concrete validation in all MediVet Biologics’ endeavors.
MediVet prides itself on having the latest cutting edge technologies to allow pet owners the ability to ease their beloved pet’s pain. Follow the timeline above to witness the evolution of one of the greatest technologies in veterinary medicine. MediVet’s evolution is full of university collaboration, independent research, partnerships and groundbreaking new technologies.